Multicenter registry on patients treated by the new Gore thoracic branched endoprosthesis
This is a multicenter, non-sponsored, physician-initiated multicenter registry on patients treated with the Gore thoracic branched endoprosthesis. Inclusion of centers is on a voluntary basis; each participating center includes consecutive patients treated with this device.
Study Type
OBSERVATIONAL
Enrollment
50
deployment of the GORE TAG Thoracic Branch Endoprosthesis fro thoraci aorta pathologies
Vascular and Endovascular Clinic - Padova University
Padua, Italy
early mortality
mortality related to the intervention within 30 days
Time frame: 30 days
device stability
freedom from related mortality, reintervention, type 1a endoleak during follow-up
Time frame: 5 years
technical success
succesful deployment of all endograft components at the intended site with complete aneurysm exclusion, without surgical conversion, type Ia/III endoleak, kink, stenosis, graft occlusion
Time frame: 30 days
early major adverse events
stroke, spinal cord ischemia, vascular complications, cardiac complications, respiratory insufficiency, early reintervention, acute kidney injury
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.